Predicting Physiotherapy Management of Musculoskeletal Abnormalities by 2030—A Phase-Specific Evidence-Based Protocol Integrating DNA-Level Prognostic Insights

P Muthkrishnan*

The forecasting model underpinning future adoption of phase-specific, DNA-informed physiotherapy protocols employs a hybrid methodological framework, integrating population-level epidemiological data, genomic biobank insights, and contemporary clinical adoption trends. Key assumptions include:

- The routine clinical utility of DNA-based prognostic profiling for musculoskeletal disorders by 2030, facilitated by declining costs and expanded biorepository access.

- Accelerated adoption of digital health and AI-powered rehabilitation technologies, following a sigmoidal (logistic) growth curve, sensitive to sociodemographic and policy variables.

- Stratified patient management anchored both in genomic risk and longitudinal function, enabling precision technology deployment and tailored rehabilitation intensity.

Keywords:

Published on: Dec 18, 2025 Pages: 36-39

Full Text PDF Full Text HTML DOI: 10.17352/ojor.000055
CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat